Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Acetylsalicylic Acid on Immunoparalysis Following Human Endotoxemia

NCT02922673 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT02922673
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02922673 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Acetylsalicylic Acid on Immunoparalysis Following Human Endotoxemia
Lead sponsor
Radboud University Medical Center
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2016
Completion date
September 30, 2017
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endotoxemia